| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |